Trial
NCT01590979
Randomized Double Blind Control Trial on Effects of Ranolazine on New Onset Atrial Fibrillation
UnknownTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Northwell Health
Collaborators
Gilead Sciences
Condition
Atrial Fibrillation New Onset
Intervention
Ranolazine
Why stopped
The study was terminated due to slow rate of accrual resulting in a sample size.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-03-23